When assessing the validity of a patent, you cannot ignore the dependent claims. That was the main takeaway from the recent Federal Circuit case, Research Foundation of State University of New York v. Mylan Pharmaceuticals...more
A claim term that can have different meanings or values depending on the method used to measure it renders the claim indefinite because it is impossible for a potential infringer to discern the boundaries of the claim. This...more
About Court Report: Each week we will report briefly on recently filed biotech and pharma cases.
Aptalis Pharma US Inc. et al. v. Mylan Pharamaceuticals, Inc. et al. 3:13-cv-04158; filed July 5, 2013 in the District...more
On the first day of February, the Federal Circuit rejected Impax's efforts to get out from under a preliminary injunction in a case captioned In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation. ...more
Back to Top